Chronic Lymphocytic Leukemia in Adults

Our oncologists, hematologists, and pathologists use advanced diagnostic tools and the latest treatments to manage chronic lymphocytic leukemia, a cancer of the blood and bone marrow that typically progresses slowly. Our specialists provide ongoing monitoring, care, and support to help you live with this chronic disease. We can also determine whether you can be monitored and delay treatment safely, or if you need to start tailored regimens of chemotherapy and newly approved targeted therapy to manage the condition.

Clinical Trials and Research Studies

Phase 6

A Multi-center Open-label Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To >65 Years with Newly-diagnosed Philadelphia-negative ALL

Learn More

Phase 2

A Phase IIa Open-label Clinical Trial to Evaluate the Safety Pharmacokinetics Pharmacodynamics and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More

Phase 1

A Phase 1 Open-label Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas

Learn More